ASCRS 2020: New solutions for patient, physician access from Sun Pharmaceuticals

May 16, 2020

Ophthalmology Times' Sheryl Stevenson speaks with Mark Hagler, senior vice president, head of Ophthalmics, Oncology & LTC at Sun Pharmaceuticals, on the company's ongoing research and portfolio, as well as how its operations and employees are continuing to manage and adapt amid the coronavirus pandemic, during the 2020 ASCRS virtual meeting.
 

See more ASCRS meeting coverage here